Published in Anticancer Res on July 17, 2008
Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics (2011) 1.13
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence. BMC Cancer (2009) 0.85
Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins. PLoS One (2013) 0.81
Human mammaglobin in breast cancer: a brief review of its clinical utility. Indian J Med Res (2014) 0.78
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. J Transl Med (2013) 0.75
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med (2014) 9.09
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol (2012) 5.71
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer. J Clin Oncol (2012) 2.45
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J (2004) 2.20
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res (2005) 2.11
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66
Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer. J Natl Cancer Inst (2013) 1.57
Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol (2004) 1.46
Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol Ther (2006) 1.46
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45
LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? Eur J Cancer (2007) 1.44
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial. Trials (2014) 1.39
Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol (2002) 1.34
Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol (2003) 1.31
Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst (2008) 1.30
Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer (2003) 1.21
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet (2007) 1.19
LRIG1 protein in human cells and tissues. Cell Tissue Res (2003) 1.18
The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics (2004) 1.17
Dysregulated secretoglobin expression in human lung cancers. Lung Cancer (2003) 1.17
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol (2010) 1.17
Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet (2011) 1.12
Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol (2006) 1.10
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.09
LRIG1 expression in colorectal cancer. Acta Oncol (2007) 1.08
Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol (2013) 1.06
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol (2003) 1.05
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology (2009) 1.05
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys (2005) 1.04
Characterization and tissue-specific expression of human LRIG2. Gene (2004) 1.04
The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev (2008) 1.02
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer (2011) 1.01
ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases. Anticancer Res (2009) 1.01
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer (2009) 1.00
Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology (2002) 0.99
LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix. Acta Oncol (2010) 0.99
Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol (2006) 0.97
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status. Neuro Oncol (2013) 0.97
Increased copy number at 3p14 in breast cancer. Breast Cancer Res (2005) 0.97
MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer (2009) 0.97
Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncol (2011) 0.97
Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations. Int J Cancer (2014) 0.96
Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma. Int J Oncol (2012) 0.96
An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev (2007) 0.95
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin Breast Cancer (2003) 0.95
Pharmacological modulation of lung cancer cells for potassium ion depletion. Anticancer Res (2005) 0.92
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat (2011) 0.92
PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer. Breast Cancer Res Treat (2007) 0.92
Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. Exp Cell Res (2010) 0.92
Lrig2-deficient mice are protected against PDGFB-induced glioma. PLoS One (2013) 0.91
Hypofractionated conformal stereotactic radiotherapy for arteriovenous malformations. Neurosurgery (2003) 0.91
Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model. J Neurooncol (2008) 0.89
p53 Genotypes and risk of glioma and meningioma. Cancer Epidemiol Biomarkers Prev (2005) 0.89
Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors. Anticancer Res (2012) 0.89
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol (2005) 0.89
Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia. Eur J Haematol (2008) 0.89
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. J Neurooncol (2008) 0.89
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. Prostate (2007) 0.89
Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol (2014) 0.89
Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int J Cancer (2014) 0.89
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma. BMC Res Notes (2012) 0.88
Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer (2009) 0.88
Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol (2003) 0.88
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. Int J Cancer (2012) 0.88
ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family. Acta Oncol (2004) 0.88
A specialist nurse as a resource for family members to patients with brain tumors: an action research study. Cancer Nurs (2008) 0.87
Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol (2010) 0.87
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB). J Neurooncol (2006) 0.87
Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression. J Neurooncol (2012) 0.87
LRIG and cancer prognosis. Acta Oncol (2014) 0.87
Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition. Clin Cancer Res (2006) 0.86
Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol (2012) 0.86
EGFR gene variants are associated with specific somatic aberrations in glioma. PLoS One (2012) 0.86